Udit Amin - Alembic Pharmaceuticals Chief Officer
| APLLTD Stock | 1,093 51.35 4.93% |
Executive
Udit Amin is Chief Officer of Alembic Pharmaceuticals Limited
| Age | 44 |
| Address | Alembic Road, Vadodara, India, 390003 |
| Phone | 91 26 5663 7000 |
| Web | https://alembicpharmaceuticals.com |
Alembic Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.0661 % which means that it generated a profit of $0.0661 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1381 %, meaning that it generated $0.1381 on every $100 dollars invested by stockholders. Alembic Pharmaceuticals' management efficiency ratios could be used to measure how well Alembic Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At present, Alembic Pharmaceuticals' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 61.4 B, whereas Total Assets are forecasted to decline to about 40.9 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Shridhar Mishra | Network18 Media Investments | N/A | |
| Anil Maloo | Ratnamani Metals Tubes | N/A | |
| Sanchayan Paul | Network18 Media Investments | N/A | |
| Vijay Kumar | Alkali Metals Limited | 73 | |
| Nitten Gupta | Network18 Media Investments | N/A | |
| Shankar Subramanian | Cholamandalam Investment and | 56 | |
| Prashant Sanghvi | Ratnamani Metals Tubes | 44 | |
| Gayathri Kesavarapu | Alkali Metals Limited | N/A | |
| Ajay Bhatia | Cholamandalam Investment and | N/A | |
| Rajat Nigam | Network18 Media Investments | N/A | |
| Ratnesh Rukhariyar | Network18 Media Investments | 44 | |
| Aman Sharma | Cholamandalam Investment and | N/A | |
| Nilesh Wargantiwar | NRB Industrial Bearings | N/A | |
| BE CFA | NRB Industrial Bearings | 61 | |
| Pangurayirath Sujatha | Cholamandalam Investment and | 56 | |
| Sunil Alimchandani | Network18 Media Investments | 64 | |
| Sakthivel | Network18 Media Investments | 65 | |
| Avinash Kaul | Network18 Media Investments | N/A | |
| Jeeva Balakrishnan | Cholamandalam Investment and | N/A | |
| Rajnikant Patel | Ratnamani Metals Tubes | N/A | |
| Jigar Sanghvi | Ratnamani Metals Tubes | N/A | |
Management Performance
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0661 |
Alembic Pharmaceuticals Leadership Team
Elected by the shareholders, the Alembic Pharmaceuticals' board of directors comprises two types of representatives: Alembic Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alembic. The board's role is to monitor Alembic Pharmaceuticals' management team and ensure that shareholders' interests are well served. Alembic Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alembic Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Charandeep Saluja, Company Officer | ||
| Dr S, Chief Officer | ||
| Udit Amin, Chief Officer | ||
| Chandrahas Shetty, Senior Resources | ||
| Raj Baheti, CFO Finance | ||
| Manisha Saraf, Company Officer | ||
| Chirayu Amin, Executive CEO | ||
| Shaunak Amin, MD Director | ||
| Ajay Desai, Senior Finance | ||
| Gautam Chatterjee, Senior President | ||
| Nilesh Wadhwa, Head Strategy | ||
| Vinod Kamath, President Operations | ||
| Pranav Amin, Managing Director | ||
| Sudhakar Pandiyan, Head Operations |
Alembic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alembic Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0661 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 213.95 B | ||||
| Shares Outstanding | 196.56 M | ||||
| Shares Owned By Insiders | 70.76 % | ||||
| Shares Owned By Institutions | 15.74 % | ||||
| Price To Book | 4.19 X | ||||
| Price To Sales | 3.38 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Alembic Stock
Alembic Pharmaceuticals financial ratios help investors to determine whether Alembic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alembic with respect to the benefits of owning Alembic Pharmaceuticals security.